|Year : 2019 | Volume
| Issue : 2 | Page : 94-99
Association of cardiovascular risk estimate with degree of atherosclerosis in patients with type 2 diabetes mellitus
Mashkura Riyazuddeen1, Ali Hasan Faiz Karnam1, L Gopinath2, Nayyar Iqbal1
1 Department of General Medicine, PIMS, Puducherry, India
2 Department of Radiology, PIMS, Puducherry, India
|Date of Submission||02-May-2019|
|Date of Acceptance||21-May-2019|
|Date of Web Publication||14-Jan-2020|
Ali Hasan Faiz Karnam
Assistant Professor, Department of General Medicine, PIMS, Puducherry
Source of Support: None, Conflict of Interest: None
Background: Type 2 diabetes mellitus is one of the leading causes for global public health crisis mainly affecting the Asian countries. Cardivascular disease (CVD) is one of the leading contributors to morbidity and mortality for type 2 diabetes mellitus patients. Assessment of the cardiovascular risk in asymptomatic patients and advising them for proper preventive measures will help to bring down the morbidity and mortality. In this study we aim to find the correlation of carotid intima thickness (CIMT) with different risk scores estimating 10 years risk of cardiovascular disease.
Method: It is a cross sectional study involving type 2 diabetes mellitus patient of age between 20 years and 80 years, without having any previous history of cardiovascular disease, cerebrovascular accident, chronic kidney disease and connective tissue disorder. Detailed history and examination was done along with blood investigations like fasting lipid profile, HbA1c, fasting and post prandial blood glucose, blood urea and creatinine. All these data were used to estimate 10 years cardiovascular risk using different risk engines - United Kingdom Prospective Diabetes Study (UKPDS) risk engine, Framingham Risk Score (FRS), Q risk and Atherosclerotic cardio vascular disease (ASCVD). All the patients were subjected for measurement of carotid intima thickness (CIMT) by ultrasonography. Correlation coefficient was calculated using SPSS software version 18.
Result: Total 59 patient (40 males and 19 females) were included in the study. Mean age, duration of diabetes, HbA1c and CIMT were 56.3 ± 10 years, 8.1 ± 6.9 years, 8.2 ± 1.2% and 0.8 ± 0.2 mm respectively. Age, duration of diabetes, HbA1c, total cholesterol, low density cholesterol and triglyceride had significant positive correlation with CIMT (P < 0.05). Among risk score ASCVD, Q risk and UKPDS risk score had positive and significant correlation with CIMT (P < 0.05). Although, FRS had positive correlation, it was not statistically significant.
Conclusion: In the absence of South Asian specific risk estimate algorithm Q risk and UKPDS risk score can be used with caution. CIMT is well established indicator of atherosclerosis, hence it can be used to estimate cardiovascular risk and to advise preventive measures.
Keywords: Cardiovascular risk, carotid intima media thickness, type 2 diabetes mellitus
|How to cite this article:|
Riyazuddeen M, Faiz Karnam AH, Gopinath L, Iqbal N. Association of cardiovascular risk estimate with degree of atherosclerosis in patients with type 2 diabetes mellitus. J Curr Res Sci Med 2019;5:94-9
|How to cite this URL:|
Riyazuddeen M, Faiz Karnam AH, Gopinath L, Iqbal N. Association of cardiovascular risk estimate with degree of atherosclerosis in patients with type 2 diabetes mellitus. J Curr Res Sci Med [serial online] 2019 [cited 2020 Dec 3];5:94-9. Available from: https://www.jcrsmed.org/text.asp?2019/5/2/94/275779
| Introduction|| |
Type 2 diabetes mellitus is one of the leading causes for global public health crisis, mainly affecting the Asian countries. The factors contributing are rapid urbanization, sedentary lifestyle, and change in nutritional pattern. The prevalence of diabetes mellitus in India is expected to be 79.4 million by 2030. The prevalence of type 2 diabetes mellitus in South India is the highest among Indians. Cardiovascular disease (CVD) is one of the leading contributors to morbidity and mortality for type 2 diabetes mellitus patients. Cardiovascular risk factors such as hypertension, dyslipidemia, and obesity are common among patients with diabetes mellitus. Diabetes mellitus can also independently increase the risk of CVD., Assessment of the cardiovascular risk in asymptomatic patients and advising them for proper preventive measures will help to bring down morbidity and mortality. CVD has worldwide prevalence of 17.3 million/year which is expected to increase to 23.6 million by 2030. Coronary heart disease (CHD) is reported high in South India and among urban Indian population. Stroke is common in East Indian states and contributes to one-third deaths in India., Cardiovascular risk can be estimated by measuring the risk factors such as age, sex, cholesterol total, and high-density lipid (HDL), blood pressure, glycosylated hemoglobin (HbA1c), and smoking status. The various tools that are widely used to estimate the 10-year risk of CVD are United Kingdom Prospective Diabetes Study (UKPDS) risk engine, Framingham risk score (FRS), World Health Organization (WHO) risk score, ADVANCE risk score, Q risk, atherosclerotic CVD (ASCVD) risk algorithm, etc., The risk score estimated by these scoring systems either underestimates or overestimates in different ethnic groups. Since carotid intima media thickness (CIMT) has shown to predict cardiovascular events in numerous studies, hence CIMT can be used to predict accuracy of these tools. Ultrasound detection of carotid plaque and CIMT measurements can be useful for refining coronary vascular disease risk assessment in asymptomatic patients. This noninvasive approach can detect subclinical vascular disease and help identify patients at higher risk of coronary vascular disease. Increases in the thickness of the intima and media of the carotid artery, as measured noninvasively by ultrasonography, are directly associated with an increased risk of myocardial infarction and stroke in older adults without a history of CVD. Hence, in this study, we aim to find the correlation of CIMT with different risk scores estimating 10-year risk of CVD.
| Methodology|| |
It is a cross-sectional study conducted at Pondicherry Institute of Medical Sciences, Puducherry, India. The study was conducted between July and August for a period of 2 months. All type 2 diabetes mellitus patients who presented to the general medicine outpatient department or were admitted in general medicine wards were included in the study. Patients with age <20 years or >80 years were excluded. Patients with previous history of cerebrovascular accident (stroke), myocardial infarction, stable or unstable angina, coronary artery bypass graft, chronic kidney disease, peripheral vascular disease, dyslipidemia on treatment, and connective tissue disorders were also excluded from the study.
All the patients were screened at outpatient and inpatient department of general medicine. Detailed history was taken and documented. All patients who satisfied the inclusion criteria was subjected to complete general and systemic examination. Blood pressure were measured in sitting position, and hypertension was defined according to the Joint National Committee 8, that is when systolic blood pressure was more than or equal to 140 mmHg or diastolic blood pressure was more than or equal to 90 mmHg on two or more occasions or on antihypertensive medications. Diabetes mellitus was diagnosed according to the American Diabetic Association criteria when fasting blood sugar was more than or equal to 126 mg/dL or postprandial sugar was >200 mg/dL or HbA1c was >6.5% or the patient was on antidiabetic medication. All patients were subjected to blood investigations for fasting lipid profile, blood urea, serum creatinine, fasting and postprandial blood sugar, HbA1c, spot urine protein to creatinine ratio, and electrocardiogram.
CIMT was measured by B-mode ultrasonography at the Department of Radiology by the same radiologist. It was measured by standard protocol. Distal common carotid artery (CCA) was visualized by conventional vascular ultrasound in longitudinal projection. Intima media thickness (IMT) was measured at the side of greatest thickness at two points, 1 cm upstream and 1 cm downstream. The maximum thickness was measured in millimeters. Carotid plaque was defined if the thickness at a point was >50% of the rest of the intima.
The risk algorithm used in the study were UKPDS risk engine version 2.0, FRS 2008, Q risk 3 and ASCVD 2013. All these risk algorithm estimated 10 year risk for developing CVD by using different variables. Non modifiable variables like age and gender were common to all the four risk algorithm but modifiable variables were slightly different for different risk algorithm.
Risk estimate was classified as low, intermediate, and high according to the score. ASCVD risk score categorized risk as low if score is <5%, borderline: 5%–7.4%, intermediate risk: 7.5%–19.5%, and high risk: >20%. According to Q risk and Framingham risk algorithm, the score of 10%, 11%–19%, and >20% is categorized as low, intermediate, and high, respectively. UKPDS risk algorithm categorizes the risk as low if the score is 0%–15%, intermediate 15%–30%, and high >30%.
Sample size was calculated as 47 keeping alpha error of 0.05, power of 80, and expected correlation coefficient of 0.4. All qualitative variables were calculated in percentages, and quantitative variables were presented in the form of mean and standard deviation. Spearman's correlation analysis was used to evaluate associations between CVD risk and CIMT; P < 0.05 was considered statistically significant. All analysis was done using statistical software SPSS version 18 (IBM SPSS Ltd, Honk Kong).
Written consents were taken from the patients before enrolling them in the study. Ethical clearance was also taken from the institutional ethics committee (RC/17/15).
| Result|| |
A total of 80 type 2 diabetes mellitus patients were screened for the study and 59 (40 males and 19 females) were included in the study. The mean age was 56.3 years (standard deviation [SD] ± 10.1) and the mean duration of diabetes was 8.1 years (SD ± 6.9 years). The mean body mass index and HbA1c were 26.6 ± 4 and 8.2 ± 1.2, respectively [Table 1]. Age, duration of diabetes, HbA1c, triglyceride, and cholesterol had a significant positive correlation with CIMT (P < 0.05), while HDL cholesterol had nonsignificant negative correlation with CIMT [Table 2].
|Table 2: Correlation of carotid intima media thickness with various variables|
Click here to view
There was a significant positive correlation of ASCVD, Q risk score, and UKPDS risk score with CIMT.
Although FRS also has positive correlation in this study, it is insignificant [Table 3].
|Table 3: Correlation of carotid intima media thickness with different risk score|
Click here to view
| Discussion|| |
Type 2 diabetes mellitus is one of the most important risk factors for CHD. Estimation of 10-year risk of developing CHD among type 2 diabetes mellitus is important for primary prevention. According to the WHO by 2030, disability-adjusted life year lost in India due to CHD is expected to be 7.7 and 5.5 million in men and women, respectively. Patients with type 2 diabetes mellitus have fourfold higher risk of developing CHD as compared to nondiabetic and 65%–75% of death in type 2 diabetes is secondary to CHD.
Most of the risk factor for CHD affects wall of the carotid artery. A study has revealed that risk factors such as age, smoking, hypertension, and diabetes have significant relation with IMT of both CCA and internal carotid artery. In a meta-analysis of cohort study, it showed that with every 0.1 mm increase in IMT increases the risk of myocardial infarction by 10%–15% and stroke risk increases by 13%–18%. IMT of more than 1 mm is considered as abnormal. Carotid plaque is better predictor of CHD. In our study, eight out of 59 (14%) had CIMT of more than 1 mm and six (10%) of them had carotid plaque. Hirata et al. in TOOTH study found that carotid plaque has a significant association with CVD death among elderly (hazard ratio = 3.9).
Duration of diabetes is also associated with increase in CIMT. In our study, the duration of diabetes had a positive significant correlation with CIMT (r = 0.273, P < 0.05). In a cohort study by Bosevski and Stojanovska found that 86.8% of the patients had increase in CIMT over a period of 2½ years and the study also found that occurrence of carotid plaque increases with duration of diabetes mellitus.
HbA1c is not only marker of diabetic control but also has positive correlation with atherosclerosis. In a study by Singh et al., they found that patients with higher HbA1c had higher value of CIMT. In another study by Kota et al., they found that patients with type 2 diabetes mellitus had higher value of CIMT and higher CIMT was associated with occurrence of ischemic stroke. In our study, the mean CIMT was 0.8 ± 0.2 mm, similar to the study by Kota et al.
There are various risk scoring systems that have been developed for the estimation of CHD risk such as FRS, UKPDS, ADVANCE, ASCVD, and Q risk. Most of these risk scoring systems either overestimate or underestimate the risk for CHD. Risk profile of different ethnic groups varies due to their culture and lifestyle, and most of them are developed for Caucasians; hence, it is difficult to choose single-risk scoring system for the South Asian population. Although the WHO has developed a risk scoring system for South Asia, one of the studies conducted at Sri Lanka showed poor correlation with CIMT as compared to FRS and UKPDS.
In our study, ASCVD, Q risk, and UKPDS risk scoring system had a significant positive correlation with CIMT. UKPDS and Q risk scoring system have Asian Indian as one of the variables for assessing the risk, but ASCVD estimates for American White or African American; hence, ASCVD may underestimate the risk for Asian Indians. Q risk and ASCVD risk scoring system estimate the risk only on diabetic status, while UKPDS not only uses the duration of diabetes but also uses HbA1c as one of the variables for estimating the risk. Volgman et al. in a statement stated that Q risk scoring system has advantage over ASCVD risk scoring system among Asian Indians as it was validated among 2.3 million people with different ethnicity in England and Wales, and the median score for South Asians was higher as compared to other scores. Volgman et al. also concluded that the cultural aspects such as diet and lifestyle should also be included while assessing the risk of CHD, hence their modification to be recommended to high-risk patients. In another study by Tillin et al., they showed that neither FRS nor Q risk 2 algorithm performed well in estimating risk for South Asian, particularly women.
A study by Bannister et al. and van Dieren et al. concluded that UKPDS risk engine showed poor-to-moderate calibration and significantly overestimate the CHD risk. They also concluded that it needs to be revised for estimating CHD risk among type 2 diabetes mellitus.,
Various studies have shown positive and significant correlation of risk algorithm with CIMT. Herath et al. and Seon et al. concluded that both UKPDS and FRS have positive correlation with CIMT. In a study by Herath et al., UKPDS had significant positive correlation as compared to FRS which had nonsignificant correlation., In the MASALA study by Kandula et al., although it showed positive correlation of ASCVD risk algorithm with CIMT, since the population was South Asians in the United States, the study has low generalizability. The study also concluded that the cohort of the study requires follow-up to positively conclude on correlation of risk algorithm with CIMT.
Bansal et al. compared various risk algorithms with CIMT and coronary calcium score to estimate the risk of CHD. They found that Joint British Societies Risk calculator provided more accurate the cardiovascular risk estimates. The population in this study was without known coronary artery disease with age more than 30 years.
This study was conducted on a sample size of 59, which does not represent the required population. The study population was only diabetic; hence, the result cannot be applied to nondiabetic population. Although inflammatory condition like connective tissue disorder was excluded by history, still there is a possibility that patient with inflammatory condition may have been included in the study.
| Conclusion|| |
Duration of diabetes and HbA1c had significant positive correlation with CIMT in our study, along with Q risk and UKPDS risk algorithm. In view of small sample size and cross-sectional design, it is difficult to conclude that these risk algorithms can be used for estimating the cardiovascular risk among type 2 diabetes mellitus. In the absence of South Asian, specific risk scoring algorithm, Q risk, and UKPDS risk algorithm may be used. The prospective cohort study with larger sample size may be the answer for the current problem. Since CIMT is already an established risk assessment stool, we recommend that it may be used to estimate the risk and to advise preventive measures to the patient with type 2 diabetes mellitus.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Hu FB. Globalization of diabetes: The role of diet, lifestyle, and genes. Diabetes Care 2011;34:1249-57.
Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Australas Med J 2014;7:45-8.
Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, et al.
High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey. Diabetologia 2001;44:1094-101.
Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, et al.
High prevalence of diabetes and impaired glucose tolerance in India: National urban diabetes survey. Diabetologia 2001;44:1094-101.
Matheus AS, Tannus LR, Cobas RA, Palma CC, Negrato CA, Gomes MB. Impact of diabetes on cardiovascular disease: An update. Int J Hypertens 2013;2013:653789.
Lloyd-Jones DM. Cardiovascular risk prediction: Basic concepts, current status, and future directions. Circulation 2010;121:1768-77.
Smith SC Jr., Collins A, Ferrari R, Holmes DR Jr., Logstrup S, McGhie DV, et al.
Our time: A call to save preventable death from cardiovascular disease (heart disease and stroke). J Am Coll Cardiol 2012;60:2343-8.
Gupta R, Guptha S, Sharma KK, Gupta A, Deedwania P. Regional variations in cardiovascular risk factors in India: India heart watch. World J Cardiol 2012;4:112-20.
Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993;16:434-44.
Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, et al.
The Framingham and UK prospective diabetes study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: The action in diabetes and vascular disease: Preterax and diamicron-MR controlled evaluation (ADVANCE) study. Diabetologia 2010;53:821-31.
Kasliwal RR, Bansal M, Desai D, Sharma M. Carotid intima-media thickness: Current evidence, practices, and Indian experience. Indian J Endocrinol Metab 2014;18:13-22.
Wu TW, Hung CL, Liu CC, Wu YJ, Wang LY, Yeh HI. Associations of cardiovascular risk factors with carotid intima-media thickness in middle-age adults and elders. J Atheroscler Thromb 2017;24:677-86.
Ali MK, Narayan KM, Tandon N. Diabetes & coronary heart disease: Current perspectives. Indian J Med Res 2010;132:584-97.
] [Full text]
Polak JF, Pencina MJ, Meisner A, Pencina KM, Brown LS, Wolf PA, et al.
Associations of carotid artery intima-media thickness (IMT) with risk factors and prevalent cardiovascular disease: Comparison of mean common carotid artery IMT with maximum internal carotid artery IMT. J Ultrasound Med 2010;29:1759-68.
Sillesen H, Muntendam P, Adourian A, Entrekin R, Garcia M, Falk E, et al.
Carotid plaque burden as a measure of subclinical atherosclerosis: Comparison with other tests for subclinical arterial disease in the high risk plaque bioImage study. JACC Cardiovasc Imaging 2012;5:681-9.
Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, et al
. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The atherosclerosis risk in communities (ARIC) study, 1987-1993. Am J Epidemiol 1997;146:483-94.
Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: A meta-analysis. Atherosclerosis 2012;220:128-33.
Hirata T, Arai Y, Takayama M, Abe Y, Ohkuma K, Takebayashi T. Carotid plaque score and risk of cardiovascular mortality in the oldest old: Results from the TOOTH study. J Atheroscler Thromb 2018;25:55-64.
Bosevski M, Stojanovska L. Progression of carotid-artery disease in type 2 diabetic patients: A cohort prospective study. Vasc Health Risk Manag 2015;11:549-53.
Singh AS, Atam V, Chaudhary SC, Sawlani KK, Patel ML, Saraf S, et al.
Relation of glycated hemoglobin with carotid atherosclerosis in ischemic stroke patients: An observational study in Indian population. Ann Indian Acad Neurol 2013;16:185-9.
] [Full text]
Kota SK, Mahapatra GB, Kota SK, Naveed S, Tripathy PR, Jammula S, et al.
Carotid intima media thickness in type 2 diabetes mellitus with ischemic stroke. Indian J Endocrinol Metab 2013;17:716-22.
Herath HM, Weerarathna TP, Dulanjalee RB, Jayawardana MR, Edirisingha UP, Rathnayake M, et al.
Association of risk estimates of three different cardiovascular risk assessment tools with carotid intima media thickness in patients with type 2 diabetes. J Clin Diagn Res 2016;10:OC09-12.
Goff DC Jr., Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB Sr., Gibbons R, et al.
2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2014;63:2935-59.
Volgman AS, Palaniappan LS, Aggarwal NT, Gupta M, Khandelwal A, Krishnan AV, et al.
Atherosclerotic cardiovascular disease in South Asians in the United States: Epidemiology, risk factors, and treatments: A scientific statement from the American Heart Association. Circulation 2018;138:e1-34.
Tillin T, Hughes AD, Whincup P, Mayet J, Sattar N, McKeigue PM, et al.
Ethnicity and prediction of cardiovascular disease: Performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE – Southall and brent REvisited). Heart 2014;100:60-7.
Bannister CA, Poole CD, Jenkins-Jones S, Morgan CL, Elwyn G, Spasic I, et al.
External validation of the UKPDS risk engine in incident type 2 diabetes: A need for new type 2 diabetes-specific risk equations. Diabetes Care 2014;37:537-45.
van Dieren S, Peelen LM, Nöthlings U, van der Schouw YT, Rutten GE, Spijkerman AM, et al.
External validation of the UK prospective diabetes study (UKPDS) risk engine in patients with type 2 diabetes. Diabetologia 2011;54:264-70.
Seon CS, Min KW, Lee SY, Nho KW, Park SH, Koo BK, et al.
Cardiovascular risk assessment with vascular function, carotid atherosclerosis and the UKPDS risk engine in Korean patients with newly diagnosed type 2 diabetes. Diabetes Metab J 2011;35:619-27.
Kandula NR, Kanaya AM, Liu K, Lee JY, Herrington D, Hulley SB, et al.
Association of 10-year and lifetime predicted cardiovascular disease risk with subclinical atherosclerosis in South Asians: Findings from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study. J Am Heart Assoc 2014;3:e001117.
Bansal M, Kasliwal RR, Trehan N. Relationship between different cardiovascular risk scores and measures of subclinical atherosclerosis in an Indian population. Indian Heart J 2015;67:332-40.
[Table 1], [Table 2], [Table 3]